Viewing Study NCT05470504

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-02-24 @ 3:52 AM
Study NCT ID: NCT05470504
Status: RECRUITING
Last Update Posted: 2025-12-01
First Post: 2022-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Insulin Receptor Mutation View
None Partial Lipodystrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pegvisomant View
None Severe Insulin Resistance View
None Growth Hormone Inhibition View
None LIPOLYSIS View